POSEIDA THERAPEUTICSCS INC
POSEIDA THERAPEUTICSCS INC
Action · US73730P1084 · PSTX · A2PEYK (XNAS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - 0,00 % 0,00 % 1,92 % 244,40 % -37,85 %

Profil de l'entreprise pour POSEIDA THERAPEUTICSCS INC Action

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.

Fonds investis

Les fonds suivants ont investi dans : POSEIDA THERAPEUTICSCS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
16,28
Part (%)
0,04 %

Données de l'entreprise

Nom POSEIDA THERAPEUTICSCS INC
Société Poseida Therapeutics, Inc.
Symbole PSTX
Site web https://www.poseida.com
Marché d'origine XNAS NASDAQ
WKN A2PEYK
ISIN US73730P1084
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Mark J. Gergen J.D.
Capitalisation boursière 926 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,4 T
Adresse 9390 Towne Centre Drive, 92121 San Diego
Date d'introduction en bourse 2020-07-10

Symboles boursiers

Nom Symbole
Frankfurt 2RZ.F
NASDAQ PSTX

Autres actions

Les investisseurs qui détiennent POSEIDA THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
ASGN INC
ASGN INC Action
AUTODESK INC
AUTODESK INC Action
BIOGEN INC
BIOGEN INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COMGEST GROWTH INDIA DLAC
COMGEST GROWTH INDIA DLAC Fonds
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
EBAY INC
EBAY INC Action
INTEL CORP
INTEL CORP Action
KLA 19/49
KLA 19/49 Obligation
MICROSOFT CORP
MICROSOFT CORP Action
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Action
SOUTH EASTERN POWER NETWORKS PLC 5.625% NTS 30/09/30
SOUTH EASTERN POWER NETWORKS PLC 5.625% NTS 30/09/30 Obligation
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025